back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 08:00 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,044
+200 vol $5.22 each |
15,542 | |
| Filed 2026-06-18 07:58 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,431
+794 vol $9.36 each |
15,342 | |
| Filed 2026-06-18 07:55 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$730.80
+140 vol $5.22 each |
12,273 | |
| Filed 2026-06-18 07:53 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,758
+720 vol $5.22 each |
448,853 | |
| Filed 2026-06-18 07:52 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,102
+1,934 vol $9.36 each |
448,133 | |
| Filed 2026-06-18 07:49 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,884
+361 vol $5.22 each |
45,597 | |
| Filed 2026-06-18 07:48 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,199
+876 vol $9.36 each |
45,236 | |
| Filed 2026-06-18 07:45 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,393
+267 vol $5.22 each |
1,035,524 | |
| Filed 2026-06-18 07:44 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,720
+718 vol $9.36 each |
1,035,257 | |
| Filed 2026-06-18 07:41 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,545
+296 vol $5.22 each |
109,663 | |
| Filed 2026-06-18 07:40 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,505
+695 vol $9.36 each |
109,367 | |
| Filed 2026-06-18 07:36 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,095
+593 vol $5.22 each |
200,177 | |
| Filed 2026-06-18 07:34 Tx date 2026-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,244
+774 vol $9.36 each |
199,584 | |
| Older filings | ||||||
| Filed 2026-06-10 16:14 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-271,977.75
-29,403 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 16:13 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$227,285
+29,403 vol $7.73 each |
39,794 | |
| Filed 2026-06-10 16:11 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-227,285.19
-29,403 vol $7.73 each |
1,414 | |
| Filed 2026-06-10 16:03 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,443.25
-5,129 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 16:02 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$36,005
+5,129 vol $7.02 each |
15,520 | |
| Filed 2026-06-10 16:00 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-36,005.58
-5,129 vol $7.02 each |
30,817 | |
| Filed 2026-06-10 15:56 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,808.25
-1,709 vol $9.25 each |
10,391 | |